The FDA’s warning about Ambrosia Brands moringa powder has been updated to include numerous foreign countries.
The powder comes in capsule form and has been traced to an outbreak of Salmonella Newport illnesses in the United States.
The implicated capsules are sold under the Rosabella brand.
This outbreak is separate from an outbreak of Salmonella Richmond infections traced to Member’s Mark and other brands of moringa.
The new outbreak has sickened seven people from seven states. Illnesses started on dates ranging from Nov. 7, 2025, to Jan. 8 this year. Three of the patients have required hospitalization, which is a high percentage for Salmonella outbreaks. No deaths have been reported. The sick people live in Arizona, Florida, Iowa, Illinois, Indiana, Tennessee and Washington.
This outbreak is of particular interest because the strain of Salmonella causing the illnesses is resistant to all first-line antibiotics commonly recommended for the treatment of Salmonella infections.
The FDA has recommended that Ambrosia Brands LLC recall all Rosabella-brand moringa powder capsules from the market. The firm has agreed to conduct a recall only of certain lots. Please click here for a complete list of lot codes and expirations dates of potentially contaminated product.
FDA is conducting a traceback investigation to determine a source of contamination and is working with state partners to collect samples.
The previous outbreak of Salmonella Richmond infections linked to other brands of moringa leaf powder and capsules sickened 65 people across 28 states. Fourteen of the patients required hospitalization.
Customer information provided by the firm now shows that recalled product was sold to consumers in Algeria, Anguilla, Australia, Austria, Bahrain, Belgium, Bosnia and Herzegovina, Brazil, Brunei, Bulgaria, Canada, Chile, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Djibouti, Dominican Republic, Egypt, Estonia, Faroe Islands, Finland, France, French Polynesia, Georgia, Germany, Gibraltar, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Kuwait, Latvia, Lithuania, Luxembourg, Malaysia, Malta, Marshall Islands, Mexico, Nauru, New Zealand, Netherlands, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Suriname, Sweden, Switzerland, Taiwan, Thailand, Trinidad and Tobago, Turkey, United Arab Emirates, United Kingdom, Venezuela, and Zimbabwe.
The recalled product was also sold to consumers located nationwide in the United States, including American Samoa, Northern Mariana Islands, Puerto Rico, and Virgin Islands.